1-3 of 3
David Murray, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Upregulation of XAF1 by 5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Human CML Cells; Implications for Pretransplant Conditioning Therapy in Myeloid Leukemia

Benigno C. Valdez, PhD, Yang Li, David Murray, PhD, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5046.
https://doi.org/10.1182/blood.V112.11.5046.5046
Published: 2008
Journal Articles

Anti-Apoptotic Proteins, HSP90 and Activated STAT3 Contribute to Busulfan Resistance of Myeloid Leukemia Cells.

Borje S. Andersson, MD, PhD, Ben C. Valdez, PhD, David Murray, PhD, Latha Ramdas, PhD, Marcos de Lima, MD, Roy Jones, MD, PhD, Steven Kornblau, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2007) 110 (11): 3472.
https://doi.org/10.1182/blood.V110.11.3472.3472
Published: 2007
Journal Articles

Characterization of Gene Expression Associated with Cyclophosphamide Resistance in Chronic Myeloid Leukemia (CML).

Fei Bao, MD, Mary L. Nordberg, PhD, Paula Polk, MS, Amanda Sun, MD, PhD, David Murray, PhD, Borje S. Andersson, MD, PhD, Reinhold Munker, MD
Journal: Blood
Blood (2005) 106 (11): 1532.
https://doi.org/10.1182/blood.V106.11.1532.1532
Published: 2005